HMG-CoA reductase drugs for Atherosclerotic Cardiovascular Disease

3 tracked HMG-CoA reductase drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the HMG-CoA reductase page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.

1 approved / phase 41 Phase 21 preclinical / unstaged

The roster

← all HMG-CoA reductase drugs